AGILE: a Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 Treatment: an Update to the Structured Summary of a Study Protocol for a Randomised Platform Trial Letter.
Trials(2021)
Key words
COVID-19,SARS-CoV-2,Randomised controlled trial,Platform study,Master protocol,Phase I/II,Bayesian
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined